Business · 22/09/2023Updated: 10/17/2026 · 1 min read
FDA Announces Availability of Draft Guidance for Industry on Formal Meetings Between FDA and Sponsors or Applicants of Prescription Drug User Fee Act Products
Summary
The Food and Drug Administration (FDA) has released a draft guidance outlining recommendations for formal meetings between the FDA and sponsors or applicants of prescription drug products, replacing a previous guidance issued in 2017.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →